Online Patient Education Materials Related to Lipoprotein(a): Readability Assessment
- PMID: 35014955
- PMCID: PMC8790699
- DOI: 10.2196/31284
Online Patient Education Materials Related to Lipoprotein(a): Readability Assessment
Abstract
Background: Lipoprotein(a) (Lp(a)) is a highly proatherogenic lipid fraction that is a clinically significant risk modifier. Patients wanting to learn more about Lp(a) are likely to use online patient educational materials (OPEMs). However, the readability of OPEMs may exceed the health literacy of the public.
Objective: This study aims to assess the readability of OPEMs related to Lp(a). We hypothesized that the readability of these online materials would exceed the sixth grade level recommended by the American Medical Association.
Methods: Using an online search engine, we queried the top 20 search results from 10 commonly used Lp(a)-related search terms to identify a total of 200 websites. We excluded duplicate websites, advertised results, research journal articles, or non-patient-directed materials, such as those intended only for health professionals or researchers. Grade level readability was calculated using 5 standard readability metrics (automated readability index, SMOG index, Coleman-Liau index, Gunning Fog score, Flesch-Kincaid score) to produce robust point (mean) and interval (CI) estimates of readability. Generalized estimating equations were used to model grade level readability by each search term, with the 5 readability scores nested within each OPEM.
Results: A total of 27 unique websites were identified for analysis. The average readability score for the aggregated results was a 12.2 (95% CI 10.9798-13.3978) grade level. OPEMs were grouped into 6 categories by primary source: industry, lay press, research foundation and nonprofit organizations, university or government, clinic, and other. The most readable category was OPEMs published by universities or government agencies (9.0, 95% CI 6.8-11.3). The least readable OPEMs on average were the ones published by the lay press (13.0, 95% CI 11.2-14.8). All categories exceeded the sixth grade reading level recommended by the American Medical Association.
Conclusions: Lack of access to readable OPEMs may disproportionately affect patients with low health literacy. Ensuring that online content is understandable by broad audiences is a necessary component of increasing the impact of novel therapeutics and recommendations regarding Lp(a).
Keywords: health education; health literacy; lipoprotein(a); online patient education material; readability.
©Keon Pearson, Summer Ngo, Eson Ekpo, Ashish Sarraju, Grayson Baird, Joshua Knowles, Fatima Rodriguez. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 11.01.2022.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures



Similar articles
-
Readability and reliability of online patient education materials about statins.Am J Prev Cardiol. 2023 Sep 29;16:100594. doi: 10.1016/j.ajpc.2023.100594. eCollection 2023 Dec. Am J Prev Cardiol. 2023. PMID: 37822580 Free PMC article.
-
Readability of online patient education materials for shoulder instability surgery in English and Spanish.J Shoulder Elbow Surg. 2024 Oct;33(10):2220-2229. doi: 10.1016/j.jse.2024.02.028. Epub 2024 Apr 4. J Shoulder Elbow Surg. 2024. PMID: 38582252
-
Readability of Spanish-Language Online Patient Educational Materials for Peripheral Artery Disease Do Not Meet Recommended Standards and Represent a Literacy Barrier to Care.Ann Vasc Surg. 2024 Apr;101:157-163. doi: 10.1016/j.avsg.2023.10.029. Epub 2023 Dec 26. Ann Vasc Surg. 2024. PMID: 38154492
-
The Readability of AAOS Patient Education Materials: Evaluating the Progress Since 2008.J Bone Joint Surg Am. 2016 Sep 7;98(17):e70. doi: 10.2106/JBJS.15.00658. J Bone Joint Surg Am. 2016. PMID: 27605695 Review.
-
Readability assessment of patient educational materials for pediatric spinal conditions from top academic orthopedic institutions.J Child Orthop. 2023 May 16;17(3):284-290. doi: 10.1177/18632521231156435. eCollection 2023 Jun. J Child Orthop. 2023. PMID: 37288046 Free PMC article. Review.
Cited by
-
Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations.Am Heart J Plus. 2023 Nov 24;38:100350. doi: 10.1016/j.ahjo.2023.100350. eCollection 2024 Feb. Am Heart J Plus. 2023. PMID: 38510747 Free PMC article.
-
Evaluation of Prompts to Simplify Cardiovascular Disease Information Generated Using a Large Language Model: Cross-Sectional Study.J Med Internet Res. 2024 Apr 22;26:e55388. doi: 10.2196/55388. J Med Internet Res. 2024. PMID: 38648104 Free PMC article.
-
Readability of Hospital Online Patient Education Materials Across Otolaryngology Specialties.Laryngoscope Investig Otolaryngol. 2025 Feb 14;10(1):e70101. doi: 10.1002/lio2.70101. eCollection 2025 Feb. Laryngoscope Investig Otolaryngol. 2025. PMID: 39958944 Free PMC article.
-
Assessing the Efficacy of Large Language Models in Health Literacy: A Comprehensive Cross-Sectional Study.Yale J Biol Med. 2024 Mar 29;97(1):17-27. doi: 10.59249/ZTOZ1966. eCollection 2024 Mar. Yale J Biol Med. 2024. PMID: 38559461 Free PMC article.
-
Development, optimization, and preliminary evaluation of a novel artificial intelligence tool to promote patient health literacy in radiology reports: The Rads-Lit tool.PLoS One. 2025 Sep 3;20(9):e0331368. doi: 10.1371/journal.pone.0331368. eCollection 2025. PLoS One. 2025. PMID: 40901830 Free PMC article.
References
-
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Jun 18;139(25):e1082–e1143. doi: 10.1161/CIR.0000000000000625. https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000000625?url_ver... - DOI - DOI - PMC - PubMed
-
- Pearson K, Rodriguez F. Lipoprotein(a) and cardiovascular disease prevention across diverse populations. Cardiol Ther. 2020 Dec;9(2):275–292. doi: 10.1007/s40119-020-00177-4. http://europepmc.org/abstract/MED/32451810 10.1007/s40119-020-00177-4 - DOI - PMC - PubMed
-
- Madsen CM, Kamstrup PR, Langsted A, Varbo A, Nordestgaard BG. Lipoprotein(a)-lowering by 50 mg/dL (105 nmol/L) may be needed to reduce cardiovascular disease 20% in secondary prevention: a population-based study. Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):255–266. doi: 10.1161/ATVBAHA.119.312951. https://www.ahajournals.org/doi/abs/10.1161/ATVBAHA.119.312951?url_ver=Z... - DOI - DOI - PubMed
-
- O'Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS. Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk. Circulation. 2019 Mar 19;139(12):1483–1492. doi: 10.1161/CIRCULATIONAHA.118.037184. - DOI - PubMed
-
- Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG, ODYSSEY OUTCOMES Committees and Investigators Effect of alirocumab on lipoprotein(a) and cardiovascular risk after acute coronary syndrome. J Am Coll Cardiol. 2020 Jan 21;75(2):133–144. doi: 10.1016/j.jacc.2019.10.057. https://linkinghub.elsevier.com/retrieve/pii/S0735-1097(19)38464-5 S0735-1097(19)38464-5 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous